Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.

MLA

Yam, Clinton, et al. “Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 27, no. 19, Oct. 2021, pp. 5365–75. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-21-0144.

APA

Yam, C., Yen, E.-Y., Chang, J. T., Bassett, R. L., Alatrash, G., Garber, H., Huo, L., Yang, F., Philips, A. V., Ding, Q.-Q., Lim, B., Ueno, N. T., Kannan, K., Sun, X., Sun, B., Parra Cuentas, E. R., Symmans, W. F., White, J. B., Ravenberg, E., … Mittendorf, E. A. (2021). Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 27(19), 5365–5375. https://doi.org/10.1158/1078-0432.CCR-21-0144

Chicago

Yam, Clinton, Er-Yen Yen, Jeffrey T Chang, Roland L Bassett, Gheath Alatrash, Haven Garber, Lei Huo, et al. 2021. “Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 27 (19): 5365–75. doi:10.1158/1078-0432.CCR-21-0144.